Carl H. June joins 100 pioneers, artists, leaders, icons, and titans in TIME Magazine’s annual list of the world’s most influential people. TIME 100 recognized June for his work in developing an experimental cancer treatment called CAR-T, the world’s first gene-based cancer therapy. The list highlights individuals whose influence is not just current, but will have a lasting impact in the future.
At the Perelman School of Medicine, June is the Richard W. Vague Professor in Immunotherapy, and the director of both the Center for Cellular Immunotherapy and the Parker Institute for Cancer Immunotherapy. His clinical trials for CAR-T began in 2010, and in August of 2017 the FDA approved the therapy, which trains a patient’s own healthy cells to attack the body’s cancer cells.
Read more about June’s work and a link to the TIME 100 list at Penn Medicine News.
